Avid Bioservices, Inc. (CDMO)
Feb 5, 2025 - CDMO was delisted (reason: acquired by GHO & Ampersand)
12.49
0.00 (0.00%)
Inactive · Last trade price on Feb 4, 2025
Avid Bioservices Cash Flow Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 |
Net Income | -152.05 | -140.75 | 0.26 | 127.67 | 11.21 | -10.47 |
Depreciation & Amortization | 12.47 | 11.11 | 7.21 | 4.48 | 3.45 | 3.09 |
Other Amortization | 1.45 | 1.5 | 1.05 | 1.03 | 0.92 | - |
Loss (Gain) From Sale of Assets | 0.18 | 0.23 | 0.14 | 0.38 | - | 0.01 |
Stock-Based Compensation | 11.06 | 9.73 | 10.98 | 7.38 | 3.85 | 2.5 |
Other Operating Activities | 118.7 | 115.69 | 1.33 | -115.08 | - | - |
Change in Accounts Receivable | -5.99 | -1.1 | -1.99 | -0.96 | -13.05 | -0.21 |
Change in Inventory | 10.51 | 13.53 | -17.85 | -14.19 | -0.99 | -4.33 |
Change in Accounts Payable | -6.58 | 7.13 | 0.96 | -0.94 | -0.61 | 0.8 |
Change in Unearned Revenue | 5.51 | 2.54 | -16.45 | 3.03 | 21.65 | 14.47 |
Change in Other Net Operating Assets | 10 | -8.65 | 1.63 | -3.33 | 4.74 | -0.05 |
Operating Cash Flow | 5.26 | 10.95 | -12.72 | 9.47 | 31.18 | 5.83 |
Operating Cash Flow Growth | 137.70% | - | - | -69.65% | 435.13% | - |
Capital Expenditures | -14.94 | -31.81 | -77.8 | -56.41 | -9.86 | -3.81 |
Investing Cash Flow | -14.94 | -31.81 | -77.8 | -56.41 | -9.86 | -3.81 |
Short-Term Debt Issued | - | - | - | - | - | 4.38 |
Long-Term Debt Issued | - | 163.04 | - | - | 138.46 | - |
Total Debt Issued | 155.63 | 163.04 | - | - | 138.46 | 4.38 |
Short-Term Debt Repaid | - | - | - | - | -4.38 | - |
Long-Term Debt Repaid | - | -144.37 | -0.51 | -0.16 | -12.93 | -0.08 |
Total Debt Repaid | -145.08 | -144.37 | -0.51 | -0.16 | -17.31 | -0.08 |
Net Debt Issued (Repaid) | 10.55 | 18.67 | -0.51 | -0.16 | 121.16 | 4.3 |
Issuance of Common Stock | 1.12 | 1.4 | 3.41 | 3.36 | 38.48 | 1.12 |
Preferred Dividends Paid | - | - | - | - | -4.46 | -4.33 |
Dividends Paid | - | - | - | - | -4.46 | -4.33 |
Other Financing Activities | - | - | - | - | -5.8 | - |
Financing Cash Flow | 11.67 | 20.07 | 2.9 | 3.2 | 112.34 | 1.1 |
Net Cash Flow | 1.99 | -0.79 | -87.62 | -43.75 | 133.65 | 3.11 |
Free Cash Flow | -9.68 | -20.85 | -90.53 | -46.95 | 21.32 | 2.02 |
Free Cash Flow Growth | - | - | - | - | 957.97% | - |
Free Cash Flow Margin | -6.43% | -14.90% | -60.65% | -39.25% | 22.24% | 3.38% |
Free Cash Flow Per Share | -0.15 | -0.33 | -1.42 | -0.67 | 0.36 | 0.04 |
Levered Free Cash Flow | -1.08 | -16.31 | -77.84 | -48.82 | 21.6 | 6.33 |
Unlevered Free Cash Flow | 3 | -15.1 | -77.01 | -48.17 | 21.41 | 6.34 |
Cash Interest Paid | 6.42 | 2.56 | 1.12 | 1.67 | 0.01 | 0.01 |
Cash Income Tax Paid | 0.03 | 0.02 | 0.26 | 0.06 | - | - |